India took a much-needed step in the fight against obesity and diabetes with the introduction of Mounjaro (tirzepatide), a ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

Popular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

With the increasing popularity of weight-loss and diabetes medications worldwide, US pharmaceutical giant Eli Lilly has ...

Primarily aimed to help manage type 2 diabetes better, Mounjaro is a wonder drug associated with weight loss, something similar to Ozempic.

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been ...